The FDA Group's Nicholas Capman welcomes Jen Chew, Vice President of Solutions and Consulting at Bristlecone, to discuss how life sciences companies can effectively implement AI in their supply chain operations. Jen sheds light on a few practical approaches to AI adoption in an industry still adapting to post-COVID realities.
Discussion points include:
- Strategic Implementation Approach: Jen emphasizes the importance of starting with simple, tactical applications before moving to complex strategic implementations. She advocates for a focused departmental approach rather than scattered company-wide experimentation.
- Data Quality and Regulatory Compliance: A major focus is placed on the critical role of data quality, particularly in regulated environments. Jen stresses that life sciences companies must build robust, FDA-validatable datasets before implementing AI solutions.
- Transforming Core Processes: The conversation explores how AI could revolutionize key operations like Sales and Operations Planning (S&OP), potentially reducing multi-day sessions to just hours through pre-run scenarios and more efficient planning.
- Organizational Readiness: Jen discusses how companies can assess their AI readiness and build internal capabilities, warning against the temptation to wait for enterprise vendors like SAP to provide complete solutions.
- Future Outlook: Looking ahead to 2025, Jen predicts massive data projects will be crucial, emphasizing how organizations must combine industry-specific knowledge with their unique data to create competitive advantages in AI implementation.
____
The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus in Quality Assurance, Regulatory Affairs, and Clinical Operations.
For project or resource needs, visit: thefdagroup.com.
